Please provide your email address to receive an email when new articles are posted on . Average annual injectable drug expenditures for in-center hemodialysis were $20,000. Total annual costs were ...

DUBLIN--(BUSINESS WIRE)--The "Hemodialysis & Peritoneal Dialysis Market (2025 Edition): Analysis By Product (Machines, Dialyzers, Dialysis Solutions, and Catheters & Accessories), By End-User, By Type ...

In a large observational study of patients receiving home kidney dialysis, home hemodialysis was associated with improvements in key cardiovascular outcomes compared with peritoneal dialysis; however, ...

Please provide your email address to receive an email when new articles are posted on . Editor's note: After more than 20 years on in-center hemodialysis, Jennifer Castillo decided it was time to go ...

NxStage Medical, Inc. (Nasdaq: NXTM) is encouraging patients to take control of their dialysis therapy and consider home hemodialysis in the wake of a new study that found patient survivability rates ...

FutureWise Research, a leading provider of industry intelligence, today announced the release of its new report titled “Hemodialysis and Peritoneal Dialysis Market By Product & Services, By End User, ...

Urgent-start peritoneal dialysis is an important strategy to promote home dialysis, according to investigators. Urgent-start peritoneal dialysis (PD) is safer than urgent-start hemodialysis (HD), ...

no association between the length of storage of transfused red blood cells RBCs and patient mortality. Investigators report results of their analysis of patients in the DOPPS and PDOPPS.

CHICAGO, April 18, 2024 /PRNewswire/ -- Hemodialysis and Peritoneal Dialysis Market in terms of revenue was estimated to be worth $92.0 billion in 2024 and is poised to reach $126.2 billion by 2029, ...

KIDNEY substitutes that are effective in the management of chronic renal failure are hemodialysis and peritoneal dialysis. Scribner's technic for hemodialysis developed in 1958–59, 1 employing an ...